一二三四区视频,亚洲少妇熟女色,日本久热无码视频网,欧美国产日韩大尺度,亚洲a视频,久久少妇一区二区,日韩999无码视频,刺激久久久久久久,啊啊啊啊不要啊在线

ChemicalBook >> journal list >> Molecules >>article
Molecules

Molecules

IF: 4.2
Download PDF

Large-Scale Virtual Screening Against the MET Kinase Domain Identifies a New Putative Inhibitor Type

Published:19 February 2020 DOI: 10.3390/molecules25040938 PMID: 32093126
Emmanuel Bresso, Alessandro Furlan, Philippe Noel, Vincent Leroux, Flavio Maina, Rosanna Dono, Bernard Maigret

Abstract

By using an ensemble-docking strategy, we undertook a large-scale virtual screening campaign in order to identify new putative hits against the MET kinase target. Following a large molecular dynamics sampling of its conformational space, a set of 45 conformers of the kinase was retained as docking targets to take into account the flexibility of the binding site moieties. Our screening funnel started from about 80,000 chemical compounds to be tested in silico for their potential affinities towards the kinase binding site. The top 100 molecules selected-thanks to the molecular docking results-were further analyzed for their interactions, and 25 of the most promising ligands were tested for their ability to inhibit MET activity in cells. F0514-4011 compound was the most efficient and impaired this scattering response to HGF (Hepatocyte Growth Factor) with an IC 50 of 7.2 μ M. Interestingly, careful docking analysis of this molecule with MET suggests a possible conformation halfway between classical type-I and type-II MET inhibitors, with an additional region of interaction. This compound could therefore be an innovative seed to be repositioned from its initial antiviral purpose towards the field of MET inhibitors. Altogether, these results validate our ensemble docking strategy as a cost-effective functional method for drug development.

Similar articles

IF:3.6

Virtual Screening and Biological Evaluation of Natural Products as Novel VPS34 Inhibitors that Modulate Autophagy

ChemMedChem Xiaowen Feng, Baoming Wu,etc Published: 22 November 2024
IF:4.6

Clinical Pharmacology of Brigatinib: A Next-Generation Anaplastic Lymphoma Kinase Inhibitor.

Clinical Pharmacokinetics Neeraj Gupta, Michael J Hanley,etc Published: 1 August 2023
IF:2.3

Use of a molecular beacon based fluorescent method for assaying uracil DNA glycosylase (Ung) activity and inhibitor screening

Biochemistry and Biophysics Reports Avani Mehta , Prateek Raj ,etc Published: 1 July 2021
民丰县| 黔东| 临高县| 汝阳县| 汝阳县| 灵璧县| 安图县| 噶尔县| 营口市| 巴中市| 游戏| 乐都县| 乾安县| 田东县| 乌苏市| 荔浦县| 惠水县| 黄大仙区| 滕州市| 肃南| 和田市| 康乐县| 西畴县| 于田县| 崇阳县| 理塘县| 平邑县| 肇源县| 榆中县| 祥云县| 宽甸| 静乐县| 石河子市| 大石桥市| 鄢陵县| 宝清县| 苏州市| 启东市| 长海县| 如皋市| 原阳县|